Neuropace, Inc.

Q2 2025 13F Holders

Symbol: NPCE
CUSIP: 641288105
Type: Equity
Class: COM
Num filings: 109
Total reported value, excl. options: $251 M

Compare 2025 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type